| Net income (loss) | 1.83B |
| Provision for loan losses | |
| Deferred income taxes | |
| Depreciation and amortization on premises and equipment | |
| Amortization of deferred revenues | |
| Other depreciation and amortization | 262M |
| Gain (loss) on investment securities | |
| Loss (gain) on equipment | |
| Stock-based compensation expense | |
| Gain on purchase of business | |
| Net change in loans originated for sale | |
| (Increase) decrease in other assets | 104M |
| Increase (decrease) in accrued expenses and other liabilities | |
| Net cash provided by operating activities | |
| Maturities of other short-term investments | |
| Purchases of other short-term investments | -1.05B |
| Maturities and sales of available-for-sale investment securities | 1.28B |
| Purchases of available-for-sale investment securities | |
| Maturities of held-to-maturity investment securities | 17M |
| Purchases of held-to-maturity invetment securities | -56M |
| Net principal disbursed on loans held for investment | |
| Purchase of loan receivables | |
| Purchase of business, net of cash acquired | |
| Decrease in restricted cash-special dividend escrow | |
| Decrease (increase) in restricted cash-for securitization investors | |
| Proceeds from sale of equipment | 0 |
| Purchases of premises and equipment | -132M |
| Net cash used for investing activities | |
| Net increase (decrease) in short-term borrowings | 0 |
| Proceeds from issuance of securitized debt | 3.03B |
| Maturities of securitized debt | -2.04B |
| Proceeds from issuance of other long-term borrowings | 1.1B |
| Maturities of other long-term borrowings | |
| Proceeds from issuance of common stock | 5M |
| Purchases of treasury stock | -1.43B |
| Net increase (decrease) in deposits | 1.7B |
| Proceeds from acquisition of deposits | |
| Redemption of preferred stock | |
| Dividend paid to Morgan Stanley | |
| Dividends paid on common and preferred stock | |
| Excess tax benefits related to stock-based compensation | |
| Net cash used for financing activities | |
| Net increase (decrease) in cash and cash equivalents | 2.5B |
| Cash and cash equivalents, at beginning of period | 9.57B |
| Cash and cash equivalents, at end of period | 12.08B |
| Interest expense | |
| Income taxes, net of income tax refunds | |
| Assumption of SLC debt | |
| Special dividend-Morgan Stanley | |